Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon
Open Access
- 1 December 2011
- journal article
- clinical trial
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. 7, 761-9
Abstract
Peer reviewed article authored by (Mengden T, Hübner R, Bramlage P). Read article or submit your manuscript for publishing.Keywords
This publication has 11 references indexed in Scilit:
- Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)Vascular Health and Risk Management, 2011
- Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort studyBMJ, 2010
- Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant HypertensionArchives of internal medicine (1960), 2008
- [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with Candesartan/HCTZ].2008
- Twenty-four hour ambulatory blood pressure monitoringDMW - Deutsche Medizinische Wochenschrift, 2005
- Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting MortalityHypertension, 2005
- Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated HypertensionNew England Journal of Medicine, 2003
- Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research DesignsNew England Journal of Medicine, 2000
- Candesartan cilexetil: safety and tolerability in healthy volunteers and patients with hypertension.1997
- An Evaluation of Self-Measured Blood Pressure in a Study With a Calcium-Channel Antagonist Versus a -BlockerAmerican Journal of Hypertension, 1992